- 专利标题： HETEROBICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS
-
申请号： US15621665申请日： 2017-06-13
-
公开(公告)号： US20180002356A1公开(公告)日： 2018-01-04
- 发明人: Richard D. Caldwell , Kevin M. Guckian , Gnanasambandam Kumaravel , Wen-Cherng Lee , Edward Yin-Shiang Lin , Xiaogao Liu , Bin Ma , Daniel M. Scott , Zhan Shi , Jermaine Thomas , Arthur G. Taveras , Guo Zhu Zheng
- 申请人： BIOGEN MA INC.
- 主分类号： C07F9/6512
- IPC分类号： C07F9/6512 ; C07D263/24 ; C07D215/20 ; C07C217/58 ; C07C233/47 ; C07C229/36 ; C07F9/60 ; C07D239/80
摘要：
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.
公开/授权文献
- US10081646B2 Heterobicyclic sphingosine 1-phosphate analogs 公开/授权日：2018-09-25
信息查询
